From 26th May RNS: "The Company has received approval from the Medicines and Healthcare products Regulatory Agency (MHRA) to conduct an unplanned interim analysis on the grounds that data from the 109 COPD patients with confirmed viral infection generates useful safety, biomarker and potentially efficacy data to support ongoing trials of SNG001 in COVID-19 patients."
It's not the full COPD results, it's an "interim analysis... to support ongoing trials of SNG001 in COVID-19 patients"
I very much doubt a company would release supporting data before releasing results.
Evgen Pharma held a double blind P2 trial at the same venue, it was larger than SNG trial. All the the dataset was analysed and verified in 3wks (with loads of data) I've know doubt SNG knows the outcome of the COPD results, I believe that the COPD dataset is going to be used to assist the Covid-19 hospital trial, therefore released at same time would be highly likely.
RE: When are UOG half year result soming out?26 Jun 2020 19:15
Yeah license currently expires end of July. We have a 20% stake but like Levi says we're going for 100% with extension. 100% of 229M barrels recoverable, in the UOG investor call it says for 2021 Zeta & Jamaica farm down, I can see us having a larger slice of pie with other deep pockets investors paying in. It's got to be shareprice riser driver.